KR20100117262A - Composite of toothpaste antibiosis - Google Patents

Composite of toothpaste antibiosis Download PDF

Info

Publication number
KR20100117262A
KR20100117262A KR1020090035911A KR20090035911A KR20100117262A KR 20100117262 A KR20100117262 A KR 20100117262A KR 1020090035911 A KR1020090035911 A KR 1020090035911A KR 20090035911 A KR20090035911 A KR 20090035911A KR 20100117262 A KR20100117262 A KR 20100117262A
Authority
KR
South Korea
Prior art keywords
weight
toothpaste
tooth paste
extract
antibacterial
Prior art date
Application number
KR1020090035911A
Other languages
Korean (ko)
Other versions
KR101104548B1 (en
Inventor
한성희
Original Assignee
한성희
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한성희 filed Critical 한성희
Priority to KR1020090035911A priority Critical patent/KR101104548B1/en
Publication of KR20100117262A publication Critical patent/KR20100117262A/en
Application granted granted Critical
Publication of KR101104548B1 publication Critical patent/KR101104548B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: An antibacterial tooth paste composition for preventing dental caries and periodontal diseases is provided to ensure strong sterilizing effect to streptococcus mutans. CONSTITUTION: An antibacterial tooth paste composition contains 0.6-3.0 weight% of mixture solution containing Sophorae Radix extract and Forsythiae Fructus extract based on total weight of tooth paste base. The tooth paste base contains 15-50 weight% of abrasive of calcium carbonate, calcium pyrophosphate, calcium metaphosphate, silica, aluminum silicate, and aluminum hydroxide; 0.5-4.0 weight% of tackifier of carboxy methyl cellulose, hydroxy methyl cellulose, carrageenan, Arabia gum, and vinyl alcohol; 5.0-20 weight% of wetting agent of polyethylene glycol, sorbitol, and glycerin polyvinyl alcohol; and 10-50 weight% of perfume, saccharin, antiseptic, and purified water.

Description

항균성 치약 조성물{Composite of toothpaste antibiosis}Antimicrobial toothpaste composition {Composite of toothpaste antibiosis}

본 발명은 만병초, 고삼 및 연교로부터 얻은 수용성 추출물을 배합한 치약 조성물에 관한 것이다. 더욱 구체적으로, 본 발명은 구강질환의 예방에 효과적인 것으로 알려져 있는 만병초, 고삼, 연교의 혼합 수용성 추출물 성분 중에서, 특히 충치원인균과 치주병 원인균에 대하여 강한 살균력을 가지며, 충치원인균의 균체외 효소 글루코실트란스페라아제(Glucosyltransferase : GTase)의 분비 활성을 억제하는 항균성분을 효율적으로 배합하여 프라그 형성에 의한 충치 및 치주질환을 예방하기 위한 항균성 치약 조성물에 관한 것이다.The present invention relates to a dentifrice composition incorporating a water-soluble extract obtained from Rhododendron, Ginseng and Yeongyo. More specifically, the present invention has a strong bactericidal activity against the causative agents of caries and periodontal disease, among the mixed water-soluble extracts of Mansi, Ginseng and Fructus, which are known to be effective in the prevention of oral diseases. The present invention relates to an antimicrobial toothpaste composition for preventing tooth decay and periodontal disease caused by plaque formation by efficiently combining antimicrobial components that inhibit secretory activity of transferase (Glucosyltransferase: GTase).

일반적으로 충치는 치아우식증(Dental caries)이라고도 하며 치태내 세균, 음식물, 타액의 상호작용에 의하여 유발되는 구강내 질병 중 하나로 선진국은 물론 우리나라에서도 그 발병율이 증가하고 있다.In general, tooth decay is called dental caries, and it is one of the oral diseases caused by the interaction of bacteria, food, and saliva in the plaque, and the incidence rate is increasing in Korea as well as in developed countries.

충치원인균으로는 스트렙토코크스뮤탄스(Streptococcus mutans : S. mutans)가 주원인균으로 작용하며 구강내 치아표면에 부착하여 당의 발효에 의해 산을 발생시켜 치아표면을 파괴시키는 것으로 알려져 있다.The main cause of tooth decay is Streptococcus mutans (S. mutans), which is known to act as the main cause of bacteria and adheres to the oral tooth surface and generates acid by fermentation of sugars to destroy the tooth surface.

즉 스트렙토코크스뮤탄스는 균체표면층에 글루코실트란스페라아제(GTase)를 분비하여 음식물 중 자당(Sucrose)으로부터 불용성 다당류(Glucan)를 형성하고, 이러한 불용성 다당류는 구강내 미생물들과 치아표면에 세균막(치태)을 형성하며, 여기에 모인 세균은 당류를 분해하여 산을 생성시키고, 이 산이 치아의 에나멜 표면을 탈회시켜 충치를 진행시키게 된다. 치태가 한층 더 진행되어 치석으로 발전하게 되면 치육염, 치은염, 치조농루의 치주질환을 유발하게 된다.In other words, Streptococcus mutans secretes glucosyltransferase (GTase) into the cell surface layer to form insoluble polysaccharides (Glucan) from sucrose in food, and these insoluble polysaccharides form bacterial membranes (or plaque) on oral microorganisms and tooth surfaces. ), And the bacteria gathered here break down sugars to produce acid, which demineralizes the enamel surface of the tooth, causing the caries to progress. If plaque further progresses to tartar, it will cause periodontal disease of gingivitis, gingivitis, and alveolar pylori.

이러한 구강질환을 예방하기 위한 방법으로 치약의 주성분에 파라하이드록시안식향산에스테르, 염화페놀류, 안식황산 및 그의 염류, 불소화합물, 소디움디하이드로아세테이트, 염화스트론륨 등과 같은 방부살균제를 배합하여 사용되게 되는데, 상기 성분의 방부살균제는 충치, 치육염, 치은염, 치조농루 등의 원인이 되고 구취를 발생시키는 구강내의 미생물에 대해 살균작용을 하거나 그 대사작용을 저지시키는 작용을 하게 된다.As a method for preventing such oral diseases, a preservative disinfectant such as parahydroxybenzoic acid ester, phenolic chloride, benzoic acid and its salts, fluorine compound, sodium dihydroacetate, strontium chloride, etc. is used as a main component of toothpaste. , Antiseptic fungicides of the above ingredients cause tooth decay, gingivitis, gingivitis, alveolar pylori, and acting to sterilize or inhibit the metabolism of microorganisms in the oral cavity causing bad breath.

그러나, 일반적으로 사용되는 방부살균제는 치약 조성물 중에 함유된 계면활성제나 연마제에 의해서 불활성화되어 방부제의 활성이 저하되는 경우가 허다하였을 뿐만 아니라 한편, 방부력의 저하 또는 불활성화를 방지하기 위하여 방부살균제를 과다하게 첨가함으로 인하여 구강점막을 자극하여 부풀음, 물집 또는 홍반등을 야기시키거나 중추신경장애 등을 일으킬 수도 있으며, 불소화합물의 경우엔 치아에 반점을 유발시키기도 하는 단점들이 있었다.However, antiseptic fungicides generally used are inactivated by surfactants or abrasives contained in toothpaste compositions, and thus the activity of the preservatives is often lowered. On the other hand, antiseptic fungicides are used to prevent the reduction or inactivation of antiseptic power. Due to excessive addition of stimulation of the oral mucosa may cause swelling, blisters or erythema, or may cause central nervous system disorders, and in the case of fluorine compounds there were disadvantages that cause spots on the teeth.

상기와 같은 방부살균제를 사용함으로써 발생되는 부작용을 최소화하기 위해 각종 식물추출물을 치약 조성물에 배합하여 사용하는 기술들이 알려져 있다.In order to minimize the side effects caused by using such antiseptic fungicides, there are known techniques for combining various plant extracts with toothpaste compositions.

예를 들어, 일본 특허 제1986-197510호에서는 치주질환을 위해 차나무(Tea tree) 등 동백나무과 식물의 잎에서 추출한 추출물을 사용하고 있으나 이 경우 치약을 장기 보관하는 동안 치약 색상이 변화되거나 향이 변화면서 항균효과가 감소하거나 사용시 불쾌감을 유발하여 상품성이 떨어지는 단점이 있다.For example, Japanese Patent No. 1986-197510 uses an extract extracted from the leaves of Camellia plants such as Tea tree for periodontal disease, but in this case the toothpaste changes color or aroma during long-term storage. There is a disadvantage that the antimicrobial effect is reduced or the merchandise is inferior in use.

천연 식물추출물에 있어서 변색(갈색화 반응)이 일어나는 원인은 크게 두 가지로나누어 볼 수 있다. 첫번째는 비효소적 갈색화 반응인 마이야르(Maillard) 반응으로 치약에 사용되는 천연물이나 약효제 중에서 아미노산계 화합물의 아미노기가 알데히드 또는 캐톤기를 갖는 화합물과 반응하여 황갈색의 고분자를 형성함으로써 치약의 변색을 유발하는 것으로 치약의 장기 사용시 변색의 주원인으로 알려져 있다. 두번째는 효소적 갈변화 반응인 폴리페놀 산화효소(Polyphenol Oxidase)에 의한 갈색화로 천연 식물추출물 중에서 프라그제거나 입냄새억제에 효과적인 물질로 알려진 폴리페놀이 공기중에 노출되면서 폴리페놀 산화요소에 의해 갈색 색소인 멜라민으로 전환이 일어나면서 변색이 일어난다고 알려져 있다.The causes of discoloration (browning reaction) in natural plant extracts can be divided into two main reasons. The first is the Maillard reaction, a non-enzymatic browning reaction, which causes discoloration of toothpaste by forming a yellowish brown polymer by reacting the amino group of an amino acid compound with a compound having an aldehyde or a catone group among natural products or medicinal agents used in toothpaste. Long-term use of toothpaste is known to cause discoloration. The second is browning by polyphenol oxidase, an enzymatic browning reaction, and polyphenols known as pragze or odor inhibitors in natural plant extracts are exposed to the air. It is known that discoloration occurs as conversion to phosphorus melamine occurs.

또한, 미국 특허 제5472684호에서는 프라그제거나 치은염 치료효과를 높이기 위해 향미제로서 차나무(Tea tree)로부터 추출 정제한 차나무 오일을 사용하고 있으나 이 경우 차나무 오일의 사용량은 적당한 향미를 구현하는 함량수준에서 그 사용량이 제한될 수 밖에 없는 한계가 있다.In addition, US Pat. No. 5,526,684 uses tea tree oil extracted from tea tree as a flavoring agent to enhance the therapeutic effect of pragse or gingivitis, but in this case, the amount of tea tree oil is used at a content level that achieves an appropriate flavor. There is a limit that the usage can not be limited.

이밖에 식물추출물을 함유한 일본 특허 1984-134729(감초, 상백피), 일본 특허 제1988-253019(고추나물), 일본 특허 제1983-39614(살비아, 로즈마리), 일본 특개평 1-190624(녹차, 우롱차, 홍차), 일본 특허 제1987-48616(박하, 로즈마리), 일본 특허 제1987-58331(세네가, 개암나무)이 알려져 있으나, 이들 역시 충치원인균 및 치주질환원인균에 대한 항균효과가 떨어질 뿐 아니라 프라그형성에 중요한 역할을 하는 스트렙토코크스뮤탄스의 균체외 효소 글루코실트란스페라아제(GTase)의 활성 억제효과가 떨어지는 문제점이 있었다.In addition, Japanese Patent No. 1984-134729 (Licorice, Morus bark) containing plant extract, Japanese Patent No. 1988-253019 (Chinese Herb), Japanese Patent No. 1983-39614 (Salvia, Rosemary), Japanese Patent Laid-Open No. 1-190624 (Green tea) , Oolong tea, black tea), Japanese Patent No. 1987-48616 (mint, rosemary), Japanese Patent No. 1987-58331 (Senega, hazelnut) are known, but they also have a lower antimicrobial effect against caries and periodontal pathogens. In addition, there was a problem that the activity inhibitory effect of the extracellular enzyme glucosyltransferase (GTase) of streptococcus mutans plays an important role in the formation of plaque.

따라서, 본 발명의 목적은 살균제의 과다투여로 인하여 발생되는 구강점막 및 인체에 대한 부작용을 최소한으로 줄이면서 충치원인균과 치주병 원인균으로 알려진 스트렙토코크스뮤탄스(S. mutans)에 대한 강한 살균작용으로 충치 및 치주질환을 예방하도록 하는 항균성 치약 조성물을 제공하는 것이며, 이 항균성 치약은 구강질환의 예방에 효과적인 것으로 알려져 있는 인체에 무해한 만병초, 고삼, 연교의 혼합 수용성 추출액을 통상의 치약 베이스에 배합해 줌으로써 달성된다.Accordingly, an object of the present invention is to provide a strong bactericidal action against streptococcus mutans known as cavities and periodontal disease, while minimizing side effects on oral mucosa and human body caused by overdosage of fungicides. The present invention provides an antimicrobial toothpaste composition that prevents tooth decay and periodontal disease. The antimicrobial toothpaste is formulated with a common toothpaste base by mixing a mixed aqueous extract of Manzacho, Ginseng, and Fructus, harmless to the human body, which is known to be effective in the prevention of oral diseases. Is achieved.

본 발명의 다른 목적은 적은 양의 식물추출물로 충치 및 치주병 원인균에 대한 항균효과와 S. mutans의 균체외 GTase의 저해효과가 우수한 항균성 치약 조성물을 제공함에 있다.Another object of the present invention is to provide an antimicrobial toothpaste composition excellent in antimicrobial effect against caries and periodontal causative bacteria and inhibitory effect of extracellular GTase of S. mutans with small amount of plant extract.

본 발명의 다른 목적들은 다음의 상세한 설명으로부터 보다 명확해질 것이다.Other objects of the present invention will become more apparent from the following detailed description.

상기와 같은 목적을 달성하기 위한 본 발명에 의한 항균성 치약 조성물에 의하면, 탄산칼슘, 피로인산칼슘, 메타인산칼슘, 실리카류, 알루미늄실리케이트, 수산화알루미늄 등의 연마제 15∼50중량%, 카르복시메틸셀룰로오스, 하이드록시메틸 셀룰로오스, 카라기난, 아라비아껌, 폴리비닐알콜 등의 점증제 0.5∼4.0중량%, 폴리에틸렌글리콜류, 솔비톨, 글리세린 폴리비닐알콜 등의 습윤제 5.0∼20중량%, 라우릴황산나트륨, 소디움라우릴사르코시네이트, 모노글리세라이드설페이트, 자당지방산에스테르 등의 발포제 1.0∼2.0중량% 외에 향료, 사카린, 스테비오사이드 등의 감미제, 방부제 등의 성분을 정제수 10∼50중량%와 혼합하여 제조된 통상의 치약베이스에, 고삼 추출액, 연교 추출액, 만병초 추출액을 동률의 중량%로 혼합하고, 상기 혼합 수용성 추출액 0.6∼3.0중량%가 함유된 것을 특징으로 한다.According to the antimicrobial toothpaste composition according to the present invention for achieving the above object, 15 to 50% by weight of abrasives such as calcium carbonate, calcium pyrophosphate, calcium metaphosphate, silicas, aluminum silicate, aluminum hydroxide, carboxymethyl cellulose, 0.5 to 4.0% by weight of thickeners such as hydroxymethyl cellulose, carrageenan, gum arabic, polyvinyl alcohol, polyethylene glycols, sorbitol, 5.0 to 20% by weight of humectants such as glycerin polyvinyl alcohol, sodium lauryl sulfate, sodium lauryl sarco Ordinary toothpaste base prepared by mixing 1.0 to 2.0% by weight of foaming agents such as sinate, monoglyceride sulfate, sucrose fatty acid ester, and other components such as flavoring agents, saccharin, stevioside, and sweeteners and preservatives with 10 to 50% by weight of purified water. In the same manner, the red ginseng extract, the poncho extract, and the panacea extract were mixed at the same weight percent, and the mixed water-soluble weight It is characterized by containing the extract liquid 0.6-3.0 weight%.

본 발명의 식물추출물을 첨가하여 제조한 치약에는 불화나트륨, 모노플로로인산나트륨, 소금, 알란토인, 아미노카로익산, 비타민류, 염화아연, 염화세틸피리디움 등 치약에 통상 사용되고 있는 각종 유효성분의 첨가도 가능하다.Toothpaste prepared by the addition of the plant extract of the present invention is the addition of various active ingredients commonly used in toothpaste such as sodium fluoride, sodium monofluorophosphate, salt, allantoin, aminocaroroic acid, vitamins, zinc chloride, cetylpyrididium chloride, etc. It is also possible.

이러한 본 발명의 항균성 치약 조성물에 의하면, 고삼, 연교 및 만병초로부터 얻어진 혼합 수용성 추출액이 S. mutans에 대한 강한 살균작용을 하기 때문에 충치 및 치주질환이 예방되고, 또 GTase의 분비 활성을 억제함으로써, 프라그 형성으로 인해 발생되는 충치 및 치주질환이 예방되는 효과가 있다.According to the antimicrobial toothpaste composition of the present invention, the mixed water-soluble extract obtained from red ginseng, poncho and mandala has a strong bactericidal action against S. mutans, thus preventing caries and periodontal disease, and inhibiting the secretion activity of GTase. Tooth decay and periodontal disease caused by the formation is effective to prevent.

이하, 본 발명에 따른 항균성 치약 조성물의 바람직한 실시 예를 이하를 통해 상세히 설명하기로 한다.Hereinafter, a preferred embodiment of the antimicrobial toothpaste composition according to the present invention will be described in detail.

본 발명에 사용되는 연교는 한방에서 개나리의 열매를 말하며, 물푸레 나뭇과에 속하는 낙엽, 활엽관목으로 학명은 포시리아 코레아나(Forsythia Koreana)이 며, 열매(연교)가 열리는 개나리는 세잎 개나리로서, 가을에 여문 열매를 따서 햇볕에 말린 것을 사용한다. 연교의 성분중 과피에는 올레아놀산(oleanolic aicd), 타닌질(tannin), 필리제닌(phylligenin), 모노테르팬 배당체(프로시티드, 프로시티드모노에스테르)가 있다. 그리고 과실에는 프로시톨, 스테롤(sterol)화합물, 사피닌(sapinin: 무용혈성), 프라보놀(flavonol) 배당체류, 메테르시노시드(matairesinoside) 등이 함유되어 있으며, 동의보감에는 이 식물의 연교에서 추출한 수용성 용액이 장티프스균, 파라티프스균, 대장균, 녹농균, 등과 포도알균, 사슬알균, 폐염알균, 백일해균 등에 강한 항균작용이 있을 뿐 아니라 항균성 소염제로 염증, 배농, 독풀이, 피부병, 곪은 상처, 피부발진, 습진, 옹양종독, 여드름 등을 치료한다는 내용도 있다.The duct used in the present invention refers to the fruit of the forsythia in one shot, the deciduous, deciduous shrub belonging to the ash tree and the scientific name is Posyria correa (Forsythia Koreana), the forsythia which opens the fruit (compassion) is a three-leaved forsythia, In the fall, pick your fruit and use it to dry in the sun. Among the components of ducts, skins include oleanolic acid, tannin, phylligenin, and monoterpan glycosides (protiated, procedural monoesters). The fruit contains prostol, a sterol compound, sapinin, a flavonol glycoside, and matairesinoside. Extracted aqueous solution has strong antibacterial activity against typhoid bacteria, paratyphoid bacteria, Escherichia coli, Pseudomonas aeruginosa, and staphylococcus aureus, streptococcus, pneumonia, pertussis bacterium, as well as antibacterial anti-inflammatory agents such as inflammation, drainage, venom, skin disease, wound, skin It is said to treat rashes, eczema, toxins and acne.

또한, 최근 들어서는 0-157균과 사스(SARS) 원인균들 코로나 바이러스에 대하여 높은 항균력을 가진 것으로 알려지고 있으며, 본 발명에서는 실시 예를 통하여 치약 제형으로 적용하였을 때, 충치 및 치주병 원인균에 대한 항균효과와 GTase의 저해효과가 있는 것을 확인하였다.In addition, recently, 0-157 bacteria and SARS causative agents are known to have a high antimicrobial activity against the corona virus, in the present invention when applied as a toothpaste formulation through the embodiment, antibacterial against caries and periodontal causative bacteria It was confirmed that the effect and the inhibitory effect of GTase.

또한, 본 발명에 사용되는 고삼은, 정자나무라고 하는 양지 풀밭에 자라는 식물을 말린 것으로, 인삼의 효능과 비슷하며 맛이 쓰다. 고삼의 추출물은 살충의 기능을 가지고 있으며, 그 추출물 중에 5-알파 리덕타스(5-alfa reductase)는 위열성구취나 입이 자주 마르는 증상 및 잇몸출혈 등을 억제하는 효과가 있는 것으로 보고되고 있다.In addition, the ginseng used in the present invention is a dried plant that grows in a sunny meadow called sperm, similar to the efficacy of ginseng and bitter taste. The extract of the ginseng has the function of insecticidal, among which the 5-alpha reductase (5-alfa reductase) has been reported to have the effect of inhibiting gastric odor bad breath, dry mouth symptoms and gum bleeding.

또한, 본 발명에 사용되는 만병초는 천상초, 뚝갈나무만년초, 풍엽, 석남엽 등으로 불리며, 진달래과에 속하는 상록활엽관목으로서 학명은 로우더덴드론 브라치칼펌(Rhododendron brachycarpum)이며, 이 식물의 잎에는 안드로메도톡신, 아비쿨라린, 히페로시드, 올레아놀산 등의 성분이 들어있어, 강장, 강정, 강압, 해열, 소염, 진통 등에 뛰어난 효과가 있을 뿐 아니라 특히, 상기 성분 중에서도 안드로메도톡신은 항균작용을 하여 구강의 미생물 등의 균에 살충효과가 뛰어난 것으로 알려져 있다.In addition, the panacea used in the present invention is called cheonsangcho, cactus perennial herb, windy leaves, Seoknamyeop, etc., as the evergreen broad-leaved shrub belonging to the Rhododendron family, the scientific name is Rhododendron brachycarpum (Andromedo on the leaves of this plant) It contains ingredients such as dotoxin, abicurin, hypereroside, and oleanolic acid, which are excellent for tonic, gangjeong, coercive, antipyretic, anti-inflammatory and analgesic.In particular, andromedotoxin has antibacterial activity. It is known to have excellent insecticidal effects on bacteria such as microorganisms in the oral cavity.

본 발명의 추출물 제조 실시 예를 나타내면 다음과 같다.Representative examples of extract preparation of the present invention are as follows.

[추출물 제조 실시예]Extract Preparation Example

건조 생약재의 연교를 분쇄한 것 50g에 70%의 물 400㎖를 가하여 상온 60℃에서 각각 8시간 동안 반응시킨 후 회전증발기(Rotary Evaporator)로 감압농축하여 농축액을 20g 얻었다. 그 밖의 건조 생약재의 고삼, 만병초를 상기와 같은 방법에 따라 추출하여 각각 20g의 농축액을 얻었다.400 g of 70% water was added to 50 g of pulverized dried medicinal herb, which was reacted at room temperature for 60 hours for 8 hours, and then concentrated under reduced pressure with a rotary evaporator to obtain 20 g of a concentrate. The dried ginseng of other dry medicinal herbs and panacea were extracted in the same manner as above to obtain 20 g of concentrate.

[실시예 1]Example 1

[치약베이스에서의 항균력 측정][Antibacterial Activity Measurement in Toothpaste Base]

1) 조성물의 제조1) Preparation of the Composition

추출물 제조 실시예의 방법에 따라 제조한 생약추출물을 배합한 아래 처방의 치약을 통상의 제조방법에 따라 제조하였다.Toothpaste of the following formulation was prepared according to the conventional method of formulating the herbal extract prepared according to the method of extract preparation example.

Figure 112009501643091-PAT00001
Figure 112009501643091-PAT00001

2) 실험방법2) Experiment Method

상기 처방에 따라 제조된 치약 각각 10g을 2중량% 설탕을 함유한 브레인 허트 인퓨전 브로스(BHI) 10㎖에 첨가하여 완전히 분산시킨 후 이를 치약 농도 0.06∼0.18중량%까지 브레인 허트 인퓨전 브로스(BHI)로 희석시킨 다음 충치원인균(S. mutans : ATCC 25175)과 치주병 원인균(Actinomyces vicosus : ATCC 15987)을 접종하고 37℃ 인큐베이터에서 24시간 배양하였다. 배양후 치약 농도와 생약추출물 농도에 따른 두가지 종류의 균에 대한 항균력 실험을 하여 표 1, 2와 같은 결과를 얻었다.10 g of each toothpaste prepared according to the above formulation was added to 10 ml of Brain Hert Infusion Broth (BHI) containing 2% by weight of sugar and completely dispersed, and then, it was converted into Brain Hert Infusion Broth (BHI) to a toothpaste concentration of 0.06 to 0.18% by weight. After dilution, inoculated caries (S. mutans: ATCC 25175) and periodontal disease-causing bacteria (Actinomyces vicosus: ATCC 15987) were inoculated and incubated for 24 hours in a 37 ℃ incubator. After incubation, the antibacterial activity of the two kinds of bacteria according to the toothpaste concentration and the herbal extract concentration was obtained as shown in Tables 1 and 2.

[표 1]TABLE 1

치약베이스에서의 식물추출물에 의한 충치원인균(S. mutans : ATCC 25175)에 대한 항균력 효과Antimicrobial Activity against Toxicity of Caries (S. mutans: ATCC 25175) by Plant Extracts in Toothpaste Base

Figure 112009501643091-PAT00002
Figure 112009501643091-PAT00002

[표 2]TABLE 2

치약베이스에서의 식물추출물에 의한 치주병 원인균(Actinomyces viscosus : ATCC 1578)에 대한 항균력 효과Antimicrobial Effect of Periodontal Disease-causing Bacteria (Actinomyces viscosus: ATCC 1578) by Plant Extracts in Toothpaste Base

Figure 112009501643091-PAT00003
Figure 112009501643091-PAT00003

라우릴황산나트륨은 치약에서 발포제로서 전체 함량중 1∼2중량%를 치약베이스에 배합하는데, 그 자체도 어느 정도의 항균력이 있는 것으로 알려져 있다. 표1, 2에서 보는 바와 같이, 고삼, 연교, 만병초의 혼합 수용성 추출액을 치약 조성물중에 배합한 경우 라우릴황산나트륨만을 배합한 경우에 비해 훨씬 좋은 항균력을 나타내었다.Sodium lauryl sulfate is formulated as a blowing agent in toothpaste, 1-2% by weight of the total content in the toothpaste base, which itself is known to have some degree of antibacterial activity. As shown in Tables 1 and 2, the mixed water-soluble extracts of Ginseng, Yeongyo, and Rhododendrons in the dentifrice composition showed much better antimicrobial activity than that of sodium lauryl sulfate alone.

[실시예 2][Example 2]

[치약베이스에서의 글루코실트란스페라아제(GTase) 저해효과 측정[Measurement of Glucosyltransferase (GTase) Inhibitory Effect in Toothpaste Base

1) 조성물의 제조1) Preparation of the Composition

실험예 1에서와 동일한 방법으로 조성물을 제조하여 실험에 사용한다.The composition was prepared in the same manner as in Experimental Example 1, and used in the experiment.

2) 실험방법2) Experiment Method

① GTase 분리 및 정제① GTase Separation and Purification

스트렙토코크스뮤탄스 ATCC 25175를 3리터의 브레인 허트 인퓨전 브로스(BHI)에 접종하여 37℃ 인큐베이터에서 18시간 배양한 후 원심분리(3000rpm, 20분)하여 균체를 제거하고, 그 상층액을 황산암모늄으로 60∼70중량% 포화시킨 다음 4℃에서 18시간 방치하였다. 이렇게 하여 생성된 침전물을 원심분리(3000rpm, 20분)하여 인산칼륨 완충용액(0.05M, pH 6.5) 200㎖에 용해한 후 동일 완충용액으로 24시간 투석시켰다. 투석이 완료된 액을 다시 원심분리하여 불용물을 제거하고, 이렇게 하여 얻은 조효소 용액을 하이드록시아파타이트(Hydroxyapatite)로 충진된 컬럼에 주입시킨 후 이온강도가 다른 동일 완충용액을 단계적으로 용출시켜 정제된 GTase를 얻는다.Inoculated Streptococcus mutans ATCC 25175 into 3 liters of Brain Hert Infusion Broth (BHI), incubated in a 37 ° C incubator for 18 hours, centrifuged (3000 rpm, 20 minutes) to remove the cells, and the supernatant was ammonium sulfate. After saturation of 60 to 70 wt%, the mixture was left at 4 ° C for 18 hours. The precipitate thus produced was centrifuged (3000 rpm, 20 minutes), dissolved in 200 ml of potassium phosphate buffer (0.05 M, pH 6.5), and dialyzed with the same buffer for 24 hours. The dialysis solution was again centrifuged to remove insoluble materials. The crude enzyme solution thus obtained was injected into a column filled with hydroxyapatite, and the same buffer solution having different ionic strengths was eluted step by step to purify GTase. Get

② GTase 저해 활성 측정② Measurement of GTase Inhibition Activity

상기 방법에 의해 제조된 GTF 50∼100㎍, 설탕 70㎍ 및 0.02중량% NaN3를 함유하는 0.05M 인산칼륨완충용액(pH 6.5) 4㎖에 상기 처방에 따라 제조된 치약 각각 10g을 증류수로 치약 농도 20중량%까지 희석한 다음 원심분리(3000rpm, 20분) 를 하여 상등액을 얻었다. 이 액을 치약 농도 0.67, 1.5중량%까지 다시 희석한 후 완충용액에 가하고 37℃에서 18시간 동안 항은기를 반응시킨 후 생성된 글루칸의 양을 스펙트로포토메터에서의 흡광도(660nm)로서 측정하였다. 이 파장에서 흡광도의 감소는 글루칸의 생성억제, 즉 GTase 저해도에 비례한다. GTase 저해 활성도는 다음 식에 의해 구하였으며, 대조용액의 흡광도는 식물추출액을 제외한 반응액의 흡광도이다.10 g of each toothpaste prepared according to the above formulation was distilled into 4 ml of 0.05M potassium phosphate buffer solution (pH 6.5) containing 50 to 100 µg of GTF prepared by the above method, 70 µg of sugar, and 0.02 wt% NaN 3 . The solution was diluted to 20% by weight and then centrifuged (3000 rpm, 20 minutes) to obtain a supernatant. After diluting the solution to a toothpaste concentration of 0.67 and 1.5% by weight, it was added to a buffer solution and reacted with an anti-silver group for 18 hours at 37 ° C., and the amount of glucan produced was measured as absorbance (660 nm) in a spectrophotometer. The decrease in absorbance at this wavelength is proportional to the inhibition of glucan production, ie GTase inhibition. GTase inhibitory activity was determined by the following equation, and the absorbance of the control solution was the absorbance of the reaction solution except the plant extract.

GTase 저해활성도(%)=(1 시료용액의 흡광도/대조용액의 흡광도 ×100)GTase inhibitory activity (%) = (absorbance of 1 sample solution / absorbance of control solution × 100)

상기 방법에 의해 표 3과 같은 결과를 얻었다.The result shown in Table 3 was obtained by the said method.

[표 3][Table 3]

치약베이스에서 식물추출물에 의한 GTase 저해효과GTase Inhibitory Effect of Plant Extracts on Toothpaste Base

Figure 112009501643091-PAT00004
Figure 112009501643091-PAT00004

치약에 배합되는 라우릴황산나트륨은 약간의 GTase 저해효과가 있지만 충치예방을 위해서 만족할 만한 것이 못되므로 다른 GTase 저해물질을 첨가할 필요가 있다. 표 3에서와 같이 치약이 처방상에 고삼, 연교, 만병초와 같은 식물추출물들을 배합한 경우 라우릴황산나트륨을 함유한 경우와 비하여 훨씬 좋은 효과를 나타 내었으므로 실제 치약에 상기 추출물들을 첨가하면 GTase 저해효과에 의해 충치예방 효과를 나타낼 것으로 기대된다.Sodium lauryl sulfate in toothpaste has a slight GTase inhibitory effect, but it is not satisfactory to prevent tooth decay, so it is necessary to add another GTase inhibitor. As shown in Table 3, when toothpaste was formulated with plant extracts such as red ginseng, yeonkyo, and hyacinth on the prescription, it showed much better effect than that containing sodium lauryl sulfate. It is expected to have a caries prevention effect.

표 1-3의 결과에서 보는 바와 같이 치약 처방상에 고삼, 연교, 만병초의 혼합 수용성 추출액들을 배합한 경우, 혼합 수용성 추출액들을 배합하지 않는 치약의 경우에 비해 훨씬 좋은 충치원인균 및 치주질환원인균에 대한 항균효과 및 GTase 저해효과를 나타내었다. 따라서 본 발명에 의한 혼합식물 추출물들은 우수한 충치 및 치주질환예방 효과를 기대할 수 있다.As shown in the results of Table 1-3, the mixed water-soluble extracts of Ginseng, Yeongyo, and Manzacho were mixed in the toothpaste prescription, and compared to the toothpaste without the mixed water-soluble extracts. It showed antibacterial and GTase inhibitory effects. Therefore, the mixed plant extracts according to the present invention can expect excellent caries and periodontal disease prevention effect.

본 발명의 구체적인 실시예를 나타내면 아래와 같다.Specific embodiments of the present invention are as follows.

[실시예 3]Example 3

Figure 112009501643091-PAT00005
Figure 112009501643091-PAT00005

[실시예 4]Example 4

Figure 112009501643091-PAT00006
Figure 112009501643091-PAT00006

[실시예 5]Example 5

Figure 112009501643091-PAT00007
Figure 112009501643091-PAT00007

Claims (1)

치약베이스의 전체 중량에 대하여, 고삼 추출액, 연교 추출액, 만병초 추출액을 동률의 중량%로 혼합하고, 상기 혼합 수용성 추출액 0.6중량%∼3.0중량%를 함유한 것을 특징으로 하는 항균성 치약 조성물.An antimicrobial dentifrice composition comprising 0.6% by weight to 3.0% by weight of a mixed extract of a high ginseng extract, a poncho extract, and a panax herb extract at an equivalent rate, based on the total weight of the toothpaste base.
KR1020090035911A 2009-04-24 2009-04-24 Composite of toothpaste antibiosis KR101104548B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090035911A KR101104548B1 (en) 2009-04-24 2009-04-24 Composite of toothpaste antibiosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090035911A KR101104548B1 (en) 2009-04-24 2009-04-24 Composite of toothpaste antibiosis

Publications (2)

Publication Number Publication Date
KR20100117262A true KR20100117262A (en) 2010-11-03
KR101104548B1 KR101104548B1 (en) 2012-01-11

Family

ID=43403909

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090035911A KR101104548B1 (en) 2009-04-24 2009-04-24 Composite of toothpaste antibiosis

Country Status (1)

Country Link
KR (1) KR101104548B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021140437A1 (en) * 2020-01-08 2021-07-15 3M Innovative Properties Company Anionic alkyl sulphate component for treating caries
KR102312450B1 (en) * 2020-06-11 2021-10-13 제너럴바이오(주) Composition for prevention or improvement of oral diseases containing ginseng fermented extract and Sophora flavescens extract as an active ingredient
WO2022023523A1 (en) * 2020-07-31 2022-02-03 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4324471A1 (en) * 2022-08-15 2024-02-21 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Compositions for use in the prevention or treatment of oral or dental disorders or dysfunctions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0832620B2 (en) 1986-08-29 1996-03-29 ライオン株式会社 Oral composition
JPH08175946A (en) * 1994-12-26 1996-07-09 Kao Corp Composition for oral composition
KR100773411B1 (en) 2005-10-17 2007-11-05 안봉전 Crude drug composition showing anti-oxidative, anti-tumor and anti-bacterial activity
KR20090072848A (en) * 2007-12-29 2009-07-02 대구한의대학교산학협력단 Composition containing sophorae radix extract for the prevention and treatment of dental caries

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021140437A1 (en) * 2020-01-08 2021-07-15 3M Innovative Properties Company Anionic alkyl sulphate component for treating caries
KR102312450B1 (en) * 2020-06-11 2021-10-13 제너럴바이오(주) Composition for prevention or improvement of oral diseases containing ginseng fermented extract and Sophora flavescens extract as an active ingredient
WO2022023523A1 (en) * 2020-07-31 2022-02-03 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics

Also Published As

Publication number Publication date
KR101104548B1 (en) 2012-01-11

Similar Documents

Publication Publication Date Title
KR101641213B1 (en) Oral composition comprising Morus alba L. extract and Winged spindle extract for preventing and treating periodontal disease
KR101104548B1 (en) Composite of toothpaste antibiosis
KR940006065B1 (en) Dentifrice compositions for using carious tooth tooth root disease
KR102408893B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR101641215B1 (en) Oral composition comprising Morus alba L. extract and Winged spindle extract for preventing and treating dental caries
KR20100027746A (en) Oral composition containing natural agent
KR20170103476A (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
KR102509579B1 (en) Oral composition comprising cassava extract
KR101881636B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR102597684B1 (en) Oral composition comprising amaranth extract
Sawarkar et al. Salvadora persica L.(Miswak) An Effective Folklore Toothbrush
KR100785074B1 (en) Oral cavity composition for preventing periodontal disease and gingivitis
KR20190124073A (en) Composition containing Juniperus rigida siebold and Zucc extracts for preventing the formation of biofilm of microorganism
KR102540804B1 (en) Composition containing Torreya nucifera extracts for preventing the formation of biofilm of mmicroorgaism
KR20020082308A (en) Composition for the mouth containing extraction of Euonymus alatus Sieb
JP2004182649A (en) Composition for oral cavity
KR101344803B1 (en) Oral care composition comprising extract of machilus thunbergii and sequestering agent
KR20170103494A (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR102597685B1 (en) Oral composition comprising parsley extract
KR20170037231A (en) Oral composition comprising purslane extract
KR20190124074A (en) Composition containing Berberis amurensis extracts for preventing the formation of biofilm of microorganism
KR20170142975A (en) Composition for prevention or treatment of oral disease comprising Leonurus sibiricus extract
KR20190124075A (en) Oral Composition containing Salix graciliglans Nakai extracts

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20141016

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20151021

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20161101

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee